Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis

A fundamental process in the development and progression of heart failure is fibrotic remodeling, characterized by excessive deposition of extracellular matrix proteins in response to injury. Currently, therapies that effectively target and reverse cardiac fibrosis are lacking, warranting novel ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Bracco Gartner, Thomas C. L., Crnko, Sandra, Leiteris, Laurynas, van Adrichem, Iris, van Laake, Linda W., Bouten, Carlijn V. C., Goumans, Marie José, Suyker, Willem J. L., Sluijter, Joost P. G., Hjortnaes, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963358/
https://www.ncbi.nlm.nih.gov/pubmed/35360018
http://dx.doi.org/10.3389/fcvm.2022.854314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963358/
https://www.ncbi.nlm.nih.gov/pubmed/35360018
http://dx.doi.org/10.3389/fcvm.2022.854314

Ejemplares similares